Across the twenty-year history of the Ocean Tomo Intangible Asset Market Value Study (IAMVS), South Korea’s KOSDAQ Composite stands out. South Korea is a global technology leader, yet, on average, the KOSDAQ’s share of intangible asset value has held steady at 50% over the life of the study and fell from a peak of about […]
What Is Your Health Data Worth in a Partnership? How a Defensible Data Royalty Rate Is Built
How is a data licensing royalty rate determined? At a basic level, a defensible data licensing royalty rate starts from the ground up. Given that data is a unique asset, usable comparable license and transaction data often is not readily available. Therefore, one must begin with an enterprise-specific analysis of what each party contributes to […]
Intangible Asset Market Value in the Australian Equity Market: Australia’s Integration into the Intangible Economy
Senior IP decision-makers, specifically Chief Intellectual Property Officers (CIPOs), and partners at law firms and in-house counsel advising the ASX 200 companies, should read this article to understand: Australia’s intangible share and its 25-year trajectory. Intangible assets rose from about 65.5% of ASX 200 market capitalization in 2000 to a record 74% in 2025, a […]
Biotech Blues & The Not-So-Hidden Costs of Prior Art: Lessons in Pharma and Psychedelics
| This article was first published on les Nouvelles, March 2026 edition. In the high-stakes biotechnology and pharmaceutical industries, and in their emerging offshoots like the fast-growing psychedelics space, patents are both a cornerstone of innovation and a potential latent source of risk. At the heart of this dynamic lie prior art and freedom-to-operate […]
IP License Strategy & Optimization – The Practical Crash Course
In today’s competitive innovation economy, optimizing intellectual property and intangible asset (IP) licenses is crucial for maximizing value and ensuring sustainable growth for businesses of all shapes and sizes. When done strategically and properly, licensing can be a powerful tool for companies to unlock and optimize the value of their IP assets through collaborative innovation […]
A Trip Through the Psychedelic IP Landscape
Over the past decade, the psychedelics industry has been undergoing a second renaissance, evolving from a niche and legally questionable research area into a burgeoning field that promises to redefine mental health and wellness. As more companies, academic institutions, and non-profits explore the therapeutic potential of compounds like psilocybin, MDMA, and LSD, the role of […]
IP and Tech: Twin Engines of Innovative Sustainability
In the quest for a sustainable future, the United Nations’ Sustainable Development Goals (SDGs) represent goalposts, albeit lofty ones, that countries can aim for. These 17 interconnected goals address pressing global challenges, from climate change to income and gender inequality. Achieving these goals requires more than just lofty aspirations, however. It demands concrete action from […]
Inside the Healthcare Industry: The Growing Importance of Intellectual Property Valuations
Introduction Intellectual Property (IP) has always been important to healthcare and life sciences companies as they develop new therapies, products, and / or processes. But knowing how to value, manage, and protect their IP is a growing issue as healthcare companies think about their brands, strategic growth initiatives, investments, and how to license data. In […]